# Phosphorylation of EF-P aggravates Streptococcus suis-induced blood–brain barrier damage by enhancing serine protease production

**Authors:** Hang Yin, Yutong Tian, Zeyu Zhou, Shiqi Lang, Yuqing Li, Lianci Peng, Juan Li, Rendong Fang

PMC · DOI: 10.1186/s13567-025-01612-x · Veterinary Research · 2025-11-07

## TL;DR

Phosphorylation of EF-P in Streptococcus suis increases blood-brain barrier damage by boosting serine protease production, contributing to meningitis.

## Contribution

Identifies a novel STK/EF-P/SP signaling axis in Streptococcus suis-induced blood-brain barrier disruption.

## Key findings

- EF-P phosphorylation at Ser-148 and Thr-176 enhances bacterial virulence and ZO-1 degradation.
- EF-P regulates serine protease B9H01_03990, which contributes to blood-brain barrier damage.
- Disrupting the STK/EF-P/SP axis reduces BBB disruption in mouse models.

## Abstract

Streptococcus suis (S. suis) causes meningitis in humans and pigs. Elongation factor P (EF-P) is an important translation factor that facilitates protein synthesis with polyproline motifs. Posttranslational modification of EF-P is required for its activity and bacterial virulence. However, the regulatory mechanism of EF-P phosphorylation in S. suis-induced blood–brain barrier (BBB) disruption remains unclear. Our phosphoproteomic analysis revealed that EF-P was the key substrate of serine/threonine protein kinase (STK) in the SC19 strain. In vitro and in vivo phosphorylation assays revealed that EF-P was phosphorylated by STK at Ser-148 and Thr-176. Compared with the wild-type SC19 strain, the efp overexpression mutant strain SC19-(pSET2-EF-P) increased ZO-1 degradation in human brain endothelial cells (hCMEC/D3), the bacterial load, and the mouse survival rate; moreover, blue diffusion in the mouse brain; and brain damage, whereas the efp point mutant strain SC19-(pSET2-EF-P-T176A) abolished this enhancement effect. Furthermore, we determined that EF-P regulated the expression of the B9H01_03990 protein, which is defined as a serine protease (SP). Recombinant SP induced ZO-1 degradation in hCMEC/D3. In addition, the B9H01_03990-deficient strain (ΔB9H01_03990) alleviated ZO-1 degradation in hCMEC/D3 cells and BBB disruption in the mouse brain and transwell infection models, whereas the complementary strain CΔB9H01_03990 reversed this reduction in BBB disruption. Our study reveals that S. suis-induced BBB disruption is mediated through a novel mechanism involving EF-P phosphorylation and the proposed STK/EF-P/SP signalling axis, providing new insight into the pathogenesis of S. suis meningitis.

The online version contains supplementary material available at 10.1186/s13567-025-01612-x.

## Linked entities

- **Genes:** TRIM25 (tripartite motif containing 25) [NCBI Gene 7706], STK (K-box region and MADS-box transcription factor family protein) [NCBI Gene 826586]
- **Proteins:** TRIM25 (tripartite motif containing 25), TJP1 (tight junction protein 1)
- **Diseases:** meningitis (MONDO:0021108)
- **Species:** Streptococcus suis (taxon 1307), Homo sapiens (taxon 9606), Mus musculus (taxon 10090)

## Full-text entities

- **Diseases:** brain damage (MESH:D001925), infection (MESH:D007239), meningitis (MESH:D008580), BBB disruption (MESH:C536830)
- **Chemicals:** CDeltaB9H01 (-)
- **Species:** Sus scrofa (pig, species) [taxon 9823], Streptococcus suis (species) [taxon 1307], Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** T176A, serine/threonine
- **Cell lines:** hCMEC/D3 — Homo sapiens (Human), Transformed cell line (CVCL_U985), SC19 — Mus musculus (Mouse), Hybridoma (CVCL_C4GD)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12595652/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12595652/full.md

---
Source: https://tomesphere.com/paper/PMC12595652